Join
Live feed
·
SECFilingvia Quantisnow
Sangamo Therapeutics Inc. logo

Sangamo Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Leadership Update, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
SGMO· Sangamo Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGMO (Sangamo Therapeutics Inc.) and more on Quantisnow.